Bernard Hamelin - Concepedia

Author

Bernard Hamelin

AstraZeneca (United States)

Also Known As

B Hamelin, Bernard Hamelin

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)AstraZeneca (France)AstraZeneca (Brazil)Inserm NewYork–Presbyterian Hospital

About

Bernard Hamelin is an author at AstraZeneca (United States) specializing in medicine, pharmacotherapy, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	829
2	Cell Biology	2	2	215
3	Health Sciences	1	1	17
4	Public Health	1	1	84
5	Cellular Physiology	1	1	22

Bernard Hamelin

Publications

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial Joel E. Richter, Peter J. Kahrilas, John F. Johanson, The American Journal of Gastroenterology UrologyEsophagusGastroenterologyPharmacotherapyGerd Patients	2001	394
Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Elisabetta Cariani, Cantal Lasserre, Danielle Seurin, PubMed PathologyLiver CarcinogenesisTumor BiologyHepatobiliary TumorCancer Cell Biology	1988	193
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety David A. Johnson, Stanley B. Benjamin, Nimish Vakil, The American Journal of Gastroenterology	2001	159
Independent risk factors for hepatocellular carcinoma in french drinkers Thierry Poynard, Alain Aubert, Y. Lazizi, Hepatology Hepatitis BPathologyConsecutive DrinkersCancer Risk FactorsCirrhosis	1991	84
A Multicenter, Randomized, Double-Blind, 8-Week Comparative Trial of Standard Doses of Esomeprazole (40 mg) and Omeprazole (20 mg) for the Treatment of Erosive Esophagitis Colleen M. Schmitt, Charles J. Lightdale, Clara Hwang, Digestive Diseases and Sciences EsophagusPharmacologyGastroenterology8-Week Comparative TrialStandard Doses	2006	60
A Multicenter, Randomized, Double-Blind, 8-Week Comparative Trial of Low-Dose Esomeprazole (20 mg) and Standard-Dose Omeprazole (20 mg) in Patients with Erosive Esophagitis Charles J. Lightdale, Colleen M. Schmitt, Clara Hwang, Digestive Diseases and Sciences EsophagusEsophageal CancerMedicineGastroenterologyStandard-dose Omeprazole	2006	48
Priming of calcium mobilization in human neutrophils by granulocyte-macrophage colony-stimulating factor: Evidence for an involvement of phospholipase D-derived phosphatidic acid Paul H. Naccache, Bernard Hamelin, Muriel Gaudry, Cellular Signalling InflammationCytokineGranulocyteImmunologyHematology	1991	22
Comparison of text processing methods in social media–based signal detection Natalie Gavrielov‐Yusim, Marie‐Laure Kürzinger, Chihiro Nishikawa, Pharmacoepidemiology and Drug Safety	2019	18
The Respective Roles of Controlled Clinical Trials and Cohort Monitoring Studies in the Pre- and Postmarketing Assessment of Drugs Muriel Vray, Bernard Hamelin Therapies Drug SafetySubstance AbuseCohort Monitoring StudiesControlled Clinical TrialsPostmarketing Assessment	2005	17
How satisfied are chronic heartburn sufferers with the results they get from prescription strength heartburn medication? Joseph A. Crawley, Bernard Hamelin, Eileen Gallagher Gastroenterology Clinical EffectivenessCardiovascular DiseaseAlternative MedicineOutcomes ResearchPharmacotherapy	2000	11

Page 1